Skip to main content

Table 1 Antigenic variants of M2e fragments

From: M2e-based universal influenza vaccines: a historical overview and new approaches to development

Major feature

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

Reference

The most conservative part of M2e

S

L

L

T

E

V

E

T

P

              

[18, 51]

TCN-031 and TCN-032 antibodies recognition site

S

L

L

T

E

                  

[37]

O19 antibody recognition site

S

L

L

T

E

V

E

T

               

[32]

L18 antibody recognition site

  

L

T

E

V

E

T

P

I

R

N

           

S1 antibody recognition site

     

V

E

T

P

I

R

N

           

Influenza A and B virus neutralizing activity in vitro

S

L

L

T

E

V

E

T

P

I

R

            

[77]

Presence of B-cell epitope and 14C2 antibody recognition site

    

E

V

E

T

P

I

R

N

           

[78]

High affinity of binding with HLA-A2;

presence of T-cell epitope

 

L

L

T

E

V

E

T

P

I

             

[36]

Potential epitope

      

E

T

P

I

R

            

[94]

Presence of CTL-cell epitopes

S

L

L

T

E

V

E

T

P

I

R

N

E

W

G

        

Some critical residues for T-helpers

               

C

R

C

N

D

S

S

D

Recognition of HLA-B44-restricted CD8+ CTL line 124

     

V

E

T

P

I

R

N

E

W

         

[52]

MHC class II H-2d-restricted epitope

      

E

T

P

I

R

N

E

W

G

S

R

      

[26]

L66 antibody recognition site

S

L

L

T

E

V

E

T

P

I

R

N

E

W

G

        

[128]

N547 antibody recognition site

 

L

L

T

E

V

E

T

P

I

R

N

E

W

G

        

Z3G1 antibody recognition site

 

L

L

T

E

V

E

T

P

I

R

            

C40G1 antibody recognition site

       

T

P

I

R

N

E

          

14C2 antibody recognition site

    

E

V

E

T

P

I

R

N

E

W

        Â